Hypoxia, Epithelial-Mesenchymal Transition, and TET-Mediated Epigenetic Changes

Area of Science:

• Oncology
• Molecular Biology
• Epigenetics

Background:

• Tumor hypoxia, resulting from poor microcirculation, promotes cancer progression, epithelial-mesenchymal transition (EMT), metastasis, and chemo-resistance.
• Hypoxia-induced epigenetic alterations are critical drivers of tumor development.

Purpose of the Study:

• To investigate the role of Ten-eleven translocation (TET) proteins in hypoxia-mediated epigenetic changes and cancer development.
• To explore the interplay between hypoxia, TET1, and HIF-1α in promoting EMT and tumor progression.

Main Methods:

• Analysis of DNA demethylation mediated by TET proteins.
• Investigating TET1 expression and its co-activator role in HIF-1α transcriptional regulation.
• Evaluating the impact of hypoxia on epigenetic modifications and cancer hallmarks.

Main Results:

• TET proteins mediate DNA demethylation, inducing epigenetic changes crucial for cancer development.
• Hypoxia activates TET1, which enhances HIF-1α transcriptional activity, promoting EMT.
• HIF-1α acts as a negative prognostic factor, indicating its role in tumor progression.

Conclusions:

• Hypoxia-induced epigenetic reprogramming via TET proteins and HIF-1α signaling drives tumor malignancy.
• Hypoxia-activated prodrugs (HAPs) represent a potential therapeutic strategy to mitigate hypoxia-driven cancer progression.